REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
EUROPEAN NEUROLOGICAL DISEASE 2006 - MARCH 2006 |
|
An in-depth, thought-provoking and informative report and supporting website focusing on latest developments in clinical neuroscience and medical practice with special reference to drug therapy for diseases of the brain, central nervous system and associated mental health issues. An in-depth, thought-provoking and informative report and supporting website focusing on latest developments in clinical neuroscience and medical practice with special reference to drug therapy for diseases of the brain, central nervous system and associated mental health issues.
Contents:
Contents
Advisory Panel
Foreword
|
Foreword
Johan A Aarli President, World Federation of Neurology (WFN)
|
News Round-up
Papers Abstracts
Regulatory Issues
|
|
Regulating Stem Cell Research in Europe
Alistair M Newton Secretary-General, European Federation of Neurological Associations (EFNA), and Executive Director, European Dystonia Federation (EDF)
|
Parkinson’s Disease
|
|
State-of-the-art Therapeutic Strategies in Parkinson’s Disease
Paola Piccini and Nicola Pavese Medical Research Council Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital
|
Alzheimer’s Disease
|
|
Amyloid Precursor Protein Neurotrophic Properties As a Target to Cure Alzheimer’s Disease
André Delacourte Research Director, Research Center 815, National Institute for Health and Medical Research (Inserm)
|
Epilepsy
|
|
Modern Approaches to Epilepsy Management
Martin J Brodie Treasurer, International League Against Epilepsy (ILAE)
|
Multiple Sclerosis
|
|
Comparative Trials in Immunomodulating Treatment of Relapsing-remitting Multiple Sclerosis – The Importance of Study Design
Luca Durelli, Alessia Tavella, Giulia Contessa and Marinella Clerico Division of Neurology, Department of Clinical and Biological Science, University Hospital San Luigi Gonzaga, University of Turin
|
Pain Management
|
|
Chronic Narcotic Therapy for Patients with Chronic Non-malignant Pain
Gary W Jay Board of Advisors, American Academy of Pain Management (AAPM), and Medical Director, Headache and NeuroPain Care Institute
|
Back Pain
|
|
Lumbar Spinal Stenosis – Striving for Less Invasive Surgery
Björn Strömqvist Head, Spine Unit, Department of Orthopaedics, Lund University
|
Neurosurgery
|
|
High-frequency Stimulation of the Subthalamic Nucleus in Parkinson’s Disease
Abdelhamid Benazzouz Neurophysiologist and Research Director, National Institute for Health and Medical Research (Inserm) and National Centre for Scientific Research Unit UMR 5543, Bordeaux 2 University
|
Stroke
|
|
Pharmacotherapy of Stroke
Bartomiej Piechowski-Jó´zwiak1,2 and Julien Bogousslavsky2
1. Department of Neurology, Medical University of Warsaw, and
2. University Department of Neurology, University of Lausanne, Lausanne Stroke Program, and University Hospital of Lausanne
|
|
|
Striking Out Against Stroke
Arne Hagen President, Stroke Alliance for Europe (SAFE)
|
|
|
Stroke Units Improving the Outcome of Patients with a Cerebrovascular Event
Jacques L De Reuck Director, Stroke Unit, Department of Neurology, Ghent University Hospital and President, European Federation of Neurological Societies (EFNS)
|
|
|
Global Ischaemic Injury and Neuroprotection
Lars Wiklund Professor of Anaesthesiology and Intensive Care Medicine and Chairman, Department of Anaesthesiology and Intensive Care Medicine, Uppsala University Hospital
|
Neuropathy
|
|
Inflammation in Diabetic Neuropathies
Gérard Said Secretary-General, European Neurological Society (ENS) and Professor and Chief, Service of Neurology, University Hospital of Bicêtre
|
Psychiatry
|
|
WFSBP Guidelines for Biological Treatment of Bipolar Disorders Part I – Treatment of Bipolar Depression
Heinz Grunze, Siegfried Kasper, Guy Goodwin, Charles Bowden, David Baldwin, Rasmus Licht, Eduard Vieta, Hans-Jürgen Möller and WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
|
|
|
Developing Classification in Psychiatry – Implications of 50 Years of Progress in Psychopharmacological Therapeutics
Graham Mellsop and Selim El-Badri Professor, Waikato Clinical School, University of Auckland, and Community Psychiatrist, Waikato District Health Board
|
|
|
Looking Beyond the Monoamine Hypothesis
Johan A den Boer Professor of Biological Psychiatry, Department of Psychiatry, State University Groningen
|
Schizophrenia
|
|
Pharmacological Treatment of Schizophrenia
Istvan Bitter Professor of Psychiatry and Chair, Department of Psychiatry and Psychotherapy, Semmelweis University
|
Reference Section
|
|
Amyloid Precursor Protein Neurotrophic Properties As a Target to Cure Alzheimer’s Disease
André Delacourte Research Director, Research Center 815, National Institute for Health and Medical Research (Inserm)
|
|
|
Chronic Narcotic Therapy for Patients with Chronic Non-malignant Pain
Gary W Jay Board of Advisors, American Academy of Pain Management (AAPM), and Medical Director, Headache and NeuroPain Care Institute
|
|
|
Ramelteon – A Melatonin Receptor Agonist in the Treatment of Insomnia
Terri L Levien Drug Information Pharmacist and Clinical Assistant Professor, College of Pharmacy, Washington State University Spokane
|
|
|
Progress in Pharmacopsychiatry
Hans-Jürgen Möller Professor or Psychiatry and Chairman, Psychiatric Department, Ludwig-Maximilians-University
|
|
|
State-of-the-art Therapeutic Strategies in Parkinson’s Disease
Paola Piccini and Nicola Pavese Medical Research Council Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital
|
Technology & Services Section
|
|
Fact Sheet
Schwarz Pharma
|
|
|
|
|
|
